German drugmaker Bayer is in talks with the FDA about marketing a low-dose version of the cholesterol drug Pravachol to consumers in the US without a prescription, Bloomberg News reports.

GlaxoSmithKline continues to prepare for the rollout of its new OTC diet pill Alli.

The FDA was petitioned to approve OTC switches for Allegra (fexofenadine), Allegra D 12-hour and 24-hour (fexofenadine with pseudophedrine), and Zyrtec (cetirizine) and Zyrtec D (cetirizine with pseudophedrine).

The Family Research Council and a coalition of medical and women’s groups have filed suit to overturn the FDA’s decision to approve Plan B for OTC sales. They say the FDA lacked authority to approve the application and did so in response to political pressure.